ZBTB16 and lung carcinoma: In lung cancer, low expression of ZBTB16 may lead to excessive activation of NF - κ B signaling, promoting the infiltration of immune suppressive cells (such as regulatory T cells) and forming a pro tumor microenvironment (Hu et al., 2022).